Dhanvantri Jeevan Rekha Q1 FY27 PAT jumps threefold at Rs 18 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.6 pts more than Nifty Microcap 250 and 5.8 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved unaudited Q1 FY27 results. Net sales rose to Rs 780 lakh, up about 42 percent from Rs 551 lakh in Q1 FY26. Profit after tax tripled to Rs 18 lakh from Rs 6 lakh, with EPS at Rs 0.44 versus Rs 0.15 earlier. Total income stood at Rs 787 lakh against Rs 558 lakh. Statutory auditor Anuj Goyal and Co issued a clean limited review report. AGM scheduled for 28 September 2026.
Strong topline and bottomline growth year on year. Limited review report was clean with no qualifications. Positive operational momentum.